Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...
Q: Recently, a 47-year-old asymptomatic patient had a random prostate-specific antigen (PSA) level of 5.32 ng/mL. A repeat assay the following day was 6.10. All previous PSAs over a seven-year period ...
Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer be controlled with hormone therapy. Even in such situations, effective ...
In India, prostate cancer is often diagnosed late, making treatment harder and survival outcomes worse due to lack of ...
Prostate involvement was first reported in IgG4-RD approximately 2 decades ago and comprises only 9.6% of cases. A male patient in his 7os presented with isolated prostatitis associated with ...